In about a four year time span, small start-up Reverse Medical (Irvine, California) has quickly secured approval for a handful of products in the U.S. and Europe. The firm has been quick to build up its pipeline, and in the time it takes for some companies to simply get approval for one product, the West Coast-based company boasts that it has garnered clearance for nearly five. The firm primarily offers applications in the neurovascular market space and for revascularizing patients experiencing Acute Ischemic Stroke. (Medical Device Daily)

Boston Scientific (BSX; Natick, Massachusetts) reported approval and launch of the Ion paclitaxel-eluting platinum chromium coronary stent system, the company's third-generation drug-eluting stent (DES) technology. (Medical Device Daily)

In just a few short months patients are going to be able to do something fairly unique with their eye glasses. They're going to be able to switch between vision settings, thanks in part to a technology created by start-up PixelOptics (Roanoke, Virginia). (Medical Device Daily)

For nearly eight years my mother has been on anticoagulants. Because of this, she has to drive down to her local hospital every two weeks or so and clinicians test her blood to see if she is in danger of developing a blood clot. In theory it seems pretty simple, and pretty painless. But in reality it can be pretty taxing. Although the visits last 20 minutes or so, my mother has had to plan her life around these “events.” Vacations have been cut short and travel plans now almost always include looking for an institution that will be able...

Riverain Medical (Miamisburg, Ohio) is providing clinicians and radiologists with the perfect back-up plan to detect lung cancer in patients – and it has a peer-reviewed study to prove it. (Medical Device Daily)

NMT (Boston) is closing its doors after failing to meet endpoints in its CLOSURE I pivotal study evaluating its Starflex patent foramen ovale (PFO) closure device. Wednesday's news comes as the company has struggled in recent months to raise additional funds to support its program. (Medical Device Daily)

At first glance CardiOx (Dublin, Ohio) might seem like just another small med-tech company indistinguishable from others in its position. But the firm, which was founded in 2006, is proving itself to be anything but. Armed with a strong team of investors; a ridiculously low burn rate; and a technology that it is calling “revolutionary,“ the company is proving itself to be unique among small med-tech companies. (Medical Device Daily)

If Johnson & Johnson (J&J, New Brunswick, New Jersey) acquires Synthes (Solothurn, Switzerland) for $20 billion, it would be one of the largest med-tech deals in history. The Wall Street Journal first shed light about the possible merger between the two companies late Friday afternoon. (Medical Device Daily)

Even though hospitals and healthcare institutions are moving toward or have already adopted electronic health records (EHR) to monitor patients, few have established an electronic tracking system capable of identifying and cataloging devices used to treat these same patients. Instead many organizations find themselves in a scenario, where they are using an old-fashioned cataloging system – pen and paper – which is prone to tremendous error. (Medical Device Daily)